Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies

Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies

Tune in to hear expert guidance on the latest evidence on the comprehensive management of hyperlipidemia, including the importance of achieving LDL-C targets, addressing elevated Lp(a), optimally positioning all agents in the lipid armamentarium, and partnering with patients to reduce ASCVD risk.

  • Provider:Clinical Care Options
  • Activity Link: https://clinicaloptions.com/CE-CME/cardiology/argeting-ldl-cholesterol/18963-30700
  • Start Date: 2024-04-23 05:00:00
  • End Date: 2024-04-23 05:00:00
  • Credit Details: IPCE Credits: 1.5 hours
    AAPA Category 1 Credit™️: 1.5 hours
    AMA PRA Category 1 Credit™️: 1.5 hours
    Nursing: 1.5 hours
  • MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 175000.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Endocrinology, Diabetes, and Metabolism, Internal Medicine
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.